DTC Ads For Controlled Substances Should Stop, DEA Says
Executive Summary
The Drug Enforcement Administration is urging FDA and the pharmaceutical industry to consider the "special stature" of controlled substances when crafting advertising policy
You may also be interested in...
DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task
FDA's Office of the Chief Counsel has assigned two additional lawyers to review draft regulatory letters from the Division of Drug Marketing, Advertising & Communications
Lilly Strattera Is First ADHD Agent With Adult Indication, Full-Scale Launch
Lilly's Strattera will be the first ADHD therapy to have a traditional full-scale pharmaceutical launch
Lilly Strattera Is First ADHD Agent With Adult Indication, Full-Scale Launch
Lilly's Strattera will be the first ADHD therapy to have a traditional full-scale pharmaceutical launch